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Abstract
Aims: Omega-3 fatty acid products containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have
vasoprotective effects, in part, by stimulating the endothelial formation of nitric oxide (NO). This study determined the role
of the EPA:DHA ratio and amount, and characterized the mechanism leading to endothelial NO synthase (eNOS) activation.
Methods and Results: EPA:DHA 6:1 and 9:1 caused significantly greater endothelium-dependent relaxations in porcine
coronary artery rings than EPA:DHA 3:1, 1:1, 1:3, 1:6, 1:9, EPA and DHA alone, and EPA:DHA 6:1 with a reduced EPA + DHA
amount, which were inhibited by an eNOS inhibitor. Relaxations to EPA:DHA 6:1 were insensitive to cyclooxygenase
inhibition, and reduced by inhibitors of either oxidative stress, Src kinase, PI3-kinase, p38 MAPK, MEK, or JNK. EPA:DHA 6:1
induced phosphorylation of Src, Akt, p38 MAPK, ERK, JNK and eNOS; these effects were inhibited by MnTMPyP. EPA:DHA 6:1
induced the endothelial formation of ROS in coronary artery sections as assessed by dihydroethidium, and of superoxide
anions and hydrogen peroxide in cultured endothelial cells as assessed by electron spin resonance with the spin probe
CMH, and the Amplex Red based assay, respectively.
Conclusion: Omega-3 fatty acids cause endothelium-dependent NO-mediated relaxations in coronary artery rings, which
are dependent on the EPA:DHA ratio and amount, and involve an intracellular activation of the redox-sensitive PI3-kinase/
Akt and MAPKs pathways to activate eNOS.
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Introduction
Many prospective cohort studies and meta-analyses have
provided evidence that fish consumption, especially oily fish
(e.g., salmon, trout, herring, sardines, and mackerel), with high
amounts of omega-3 fatty acids, including eicosapentaenoic acid
(EPA, C20:5 v-3) and docosahexaenoic acid (DHA, C22:6 v-3),
or supplementation with omega-3 fatty acids reduce cardiovascu-
lar mortality in patients with heart disease [1,2]. In the GISSI-P
trial published in 1999 for patients surviving a recent myocardial
infarction, intake of 289 mg EPA plus 577 mg DHA per day
reduced significantly fatal cardiovascular diseases by 30%, fatal
coronary artery diseases by 35%, and sudden death by 45% [3].
However, more recent double-blind trials did not show an effect of
an additional amount of EPA plus DHA on major cardiovascular
endpoints in patients with coronary artery disease or after
myocardial infarction [4,5]. Such differences have been explained
by differences in study design, the fact that patients in the more
recent trials were optimally treated not only by antithrombotics
but also by antihypertensives and statins, and possibly also due to
the use of different doses, sources (oily fish or fish-oil supplements),
and formulation of EPA and/or DHA [6]. The beneficial effect of
omega-3 fatty acids on the cardiovascular system has been
suggested to involve several mechanisms and in particular their
ability to induce anti-inflammatory and anti-arrhythmic effects, to
improve the lipid profile by lowering triglyceride levels, to prevent
plaque development and possibly also to promote plaque
stabilization, and to inhibit platelet aggregation [6]. In addition,
the beneficial effect might also be due to their ability to improve
endothelial dysfunction, which may represent a very early step in
atherogenesis and is characterized by blunted endothelium-
dependent vasodilatation mostly due to a reduced bioavailability
of endothelium-derived nitric oxide (NO), and, often, endotheli-
um-derived hyperpolarization (EDH). Indeed, chronic intake of
fish oils increased endothelium-dependent relaxations in normal
and in hypercholesterolemic and atherosclerotic porcine coronary
arteries [7,8]. An improved endothelial function as assessed by
flow-mediated vasodilatation was observed in humans after intake
of fish-derived products or omega-3 fatty acids [9,10]. Moreover,
intake of EPA and DHA improved the postprandial macro- and
microvascular function in patients with type 2 diabetes mellitus
[11]. EPA has been shown to cause endothelium-dependent
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relaxations of isolated sheep pulmonary arteries, and to increase
endothelial NO synthase (eNOS) activity and NO formation in
cultured endothelial cells [12-14]. In addition, EPA but not DHA
has also been shown to cause cerebral microvascular vasodilata-
tion involving arachidonic acid metabolites [15]. On the other
hand, DHA but not EPA supplementation improved forearm
microvascular reactivity in overweight hyperlipidemic men [16].
In order to better understand the omega-3 fatty acid-induced
endothelial protection, the ability of different omega-3 fatty acid
products (EPA, DHA, different ratios of EPA:DHA, different
content of EPA and DHA) to cause endothelium-dependent
relaxations in porcine coronary arteries was evaluated. Thereafter,
the endothelium-dependent relaxation to one of the most active
omega-3 products was further characterized and in particular the
role of endothelium-derived NO, EDH and vasoactive prosta-
noids, and the signal transduction pathway leading to eNOS
activation were determined.
Materials and Methods
Vascular reactivity studies
Pig hearts were collected from the local slaughterhouse
(Copvial, Holtzheim) and vascular reactivity was assessed as
indicated previously [17,18]. Briefly, left circumflex coronary
arteries were excised, cleaned of loose connective tissue and
flushed with PBS without calcium to remove remaining blood.
Rings of porcine coronary arteries (4-5 mm in length) were then
suspended in organ baths containing oxygenated (95% O2; 5%
CO2) Krebs bicarbonate solution (composition in mM: NaCl 119,
KCl 4.7, KH2PO4 1.18, MgSO4 1.18, CaCl2 1.25, NaHCO3 25
and D-glucose 11, pH 7.4, 37uC) for the determination of changes
in isometric tension (basal tension 5 g). The integrity of the
endothelium was checked with bradykinin (0.3 mM). Rings were
contracted (about 80% maximal contraction) with U46619, a
thromboxane A2 receptor agonist, before construction of a
concentration-relaxation curve to an omega-3 fatty acid product.
In some experiments, rings were exposed to an inhibitor for
30 min before the addition of U46619.
Culture of coronary artery endothelial cells
Endothelial cells from coronary arteries were isolated from
porcine left circumflex coronary arteries by collagenase treatment
(type I, Worthington, 1 mg/ml for 12 min at 37uC), and cultured
in culture dishes containing medium MCDB 131 (Invitrogen,
Saint Aubin, France) supplemented with 15% fetal calf serum,
penicillin (100 U/ml), streptomycin (100 U/ml), fungizone
(250 mg/ml), and L-glutamine (2 mM) (all from Cambrex,
Wiesbaden, Germany), and grown for 48–72 h. Cells (first
passage) were exposed to serum-free culture medium in the
presence of 0.1% bovine serum albumin (Euromedex, Souffel-
weyersheim, France) for 6 h prior to treatment.
Western blot analysis
Endothelial cells were lysed in extraction buffer (composition in
mM: Tris/HCl 20 (Euromedex), NaCl 150, Na3VO4 1, sodium
pyrophosphate 10, NaF 20, okadaic acid 0.01, a tablet of protease
inhibitor (Complete, Roche, Meylan, France) and 1% Triton X-
100 (Euromedex); pH 7.5). Total proteins (10 mg) were separated
on 10–12% SDS-polyacrylamide gels at 100 V for 2 h. Separated
proteins were transferred electrophoretically onto polyvinylidine
difluoride membranes (GE Healthcare, Velizy-Villacoublay,
France) at 100 V for 120 min. Membranes were blocked with
buffer containing 5% bovine serum albumin, Tris-buffered saline
solution (Euromedex) and 0.1% Tween 20 (Sigma-Aldrich, Saint-
Quentin Fallavier, France) for 1 h. Membranes were incubated
with a primary antibody (p-Src Ser17, p-Akt Ser473, p-p38
MAPK Thr180/Tyr182, p-JNK Thr183/Tyr185, p-ERK
Thr202/Tyr204, p-eNOS Ser1177 from rabbit; eNOS and b-
tubulin from mouse, Cell Signaling Technology; dilution of
1:1,000) overnight at 4uC. After washing, membranes were
incubated with the appropriate horseradish peroxidase-conjugated
secondary antibody (diluted to 1:10,000 for anti-mouse antibody
and 1:5,000 for anti-rabbit antibody, Cell Signaling Technology,
Danvers, MA, USA) at room temperature for 60 min. Immuno-
reactive bands were detected by enhanced chemiluminescence
(GE Healthcare).
Determination of the vascular formation of ROS
Dihydroethidium staining. Porcine coronary arteries (5–
7 mm length) were embedded in OCT compound (Sakura
Finetek, Villeneuve d’Ascq, France) and frozen in a nitrogen bath
for cryostat sections. The redox-sensitive fluorescent dye dihy-
droethidium (DHE, 2.5 mM) was applied onto 25 mm unfixed
cryosections of coronary arteries for 30 min at 37uC in a light-
protected humidified chamber before the addition of EPA:DHA
6:1 (0.4% v/v) for 30 min. In some experiments, sections were
incubated with a pharmacological tool for 30 min at 37uC before
the addition of DHE. Sections were then washed, mounted in
fluorescence mounting medium (Dako, Les Ulis, France) and
cover-slipped. Images were obtained using a Leica SP2 UV DM
IRBE laser scanning confocal microscope (Leica Microsystem,
Nanterre, France). Quantification of staining levels was performed
using FIJI GPL v2 software.
Electron spin resonance (ESR). ESR was used to determine
whether EPA:DHA 6:1 stimulates the endothelial formation of
superoxide anions in cultured endothelial cells using the superox-
ide anion cell-permeable spin probe CMH following the method
described [19].
Endothelial cells were incubated with either solvent, SOD or
PEG-SOD followed by treatment with EPA:DHA 6:1 (0.4% v/v)
in Krebs-HEPES solution containing 500 mM of 1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidin (CMH, Noxygen,
Germany), deferoxamine (25 mM) and DETC (5 mM) under
constant temperature (37uC) for 30 min. The reaction was stopped
by putting the samples on ice, subsequently they were frozen in
liquid N2 and analyzed by ESR at 77 K in a Dewar flask using a
MS100 spectrometer (Magnettech Ltd., Berlin, Germany). Instru-
ment settings were: temperature 77 K, microwave frequency
9.34 GHz, microwave power 10 mW, amplitude of modulation
100 mT, modulation of frequency 100 kHz, and 60 s of sweep
time. Superoxide anions cannot be directly measured by ESR due
to their short half-life. Therefore, the CMH spin-trapping reagent
has been used. It reacts with superoxide anions to generate the
stable CMN radical, which gives a characteristic triplet signal ESR
spectra, with an amplitude directly proportional to the quantity of
CMN present in the sample. The quantification of the signal is
based on the mean of the height (amplitude) of the three signals.
Values are expressed in signal amplitude (Amplitude, arbitrary
units).
Amplex Red assay. Hydrogen peroxide measurements in
cultured endothelial cells were made using the horseradish
peroxidase-linked Amplex Red fluorescence assay kit as recom-
mended (Invitrogen, Paisley, UK). Endothelial cells were incubat-
ed with either solvent, catalase or PEG-catalase for 30 min and
then they were treated with EPA:DHA 6:1 (0.4% v/v) for 45 min.
Amplex Red (50 mM) and horseradish peroxidase type II (0.1 U/
ml) were added to the supernatant samples (100 ml). Fluorescence
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readings were made in triplicate in a 96-well plate, and Ex/Em
=530/580 nm.
Chemicals
All products were from Sigma-Aldrich (Saint-Quentin Fallavier,
France), except wortmannin, PP2 and MnTMPyP from Enzo Life
Sciences (Lausen, Switzerland). Omega-3 fatty acid products
(Table 1) were provided by Pivotal Therapeutics, Inc (Wood-
bridge, ON, Canada).
Statistical analysis
All values are expressed as means 6 SEM of n different
experiments. Statistical analysis was performed using Student’s
paired t test or a two-way analysis of variance test followed by
Bonferroni’s post-hoc test as appropriate using Graphpad Prism
software (version 5.04 for Windows, GraphPad Software, Inc.,
CA, USA). P,0.05 was considered to be statistically significant.
Results
The omega-3 fatty acid-induced endothelium-dependent
relaxations are dependent on the EPA:DHA ratio and
content
To study the vasoactive effect of omega-3 fatty acid products,
coronary artery rings with endothelium were contracted with
U46619 before the addition of increasing concentrations of an
omega-3 fatty acid product. Both EPA and DHA, the two major
omega-3 fatty acid products, induced concentration-dependent
relaxations in coronary artery rings with endothelium whereas no
such effect was observed in those without endothelium (Figures 1A
and B). EPA and DHA induced similar relaxations except at 0.4%
(v/v) where relaxations to EPA were slightly but significantly
greater than those to DHA (77.7610.3 and 64.6612.8%,
respectively, Figures 1A and B). Next, the ability of different
EPA:DHA ratios to induce endothelium-dependent relaxations
was determined. EPA:DHA with different ratios induced concen-
tration-dependent relaxations in intact coronary artery rings
(Figures 1A and B). However, relaxations to EPA:DHA 6:1 and
9:1 were significantly greater than those to EPA:DHA 3:1, 1:1, 1:3,
1:6, and 1:9 (Figures 1A and B). An increased relaxation was also
observed in response to an EPA:DHA 6:1 product having a high
EPA plus DHA content (694:121 mg/g) compared to one having a
low content (352:65 mg/g, Figure 1C). Altogether, these findings
indicate that omega-3 fatty acids are inducers of endothelium-
dependent relaxations in coronary artery rings, and that this effect
is dependent on the EPA:DHA ratio and on the EPA plus DHA
amount.
EPA:DHA 6:1 induces endothelium-dependent
relaxations involving predominantly NO and also, to
some extent, endothelium-dependent hyperpolarization
Next, experiments were performed to determine the role of the
different endothelium-derived relaxing factors in the EPA:DHA
6:1-induced relaxation of the coronary artery. Relaxations to
EPA:DHA 6:1 were slightly but significantly inhibited by L-NA (a
competitive inhibitor of eNOS), not affected by inhibitors of
endothelium-dependent hyperpolarization-mediated responses,
TRAM 34 plus apamin (inhibitors of Ca2+-dependent potassium
channels of intermediate and low conductance IKCa and SKCa,
respectively), and abolished by the combination of L-NA plus
TRAM 34 and apamin (Figure 1D). In addition, they were not
affected by indomethacin (cyclooxygenase inhibitor; relaxations at
0.4% v/v were 94.8 6 3.2% and 95.8 6 3.2% in the absence and
presence of indomethacin, n = 5). These findings indicate that
EPA:DHA 6:1 induces endothelium-dependent relaxations in
coronary artery rings involving predominantly NO, and also, to
some extent, EDH but not vasoactive prostanoids.
EPA:DHA 6:1 induces redox-sensitive NO-mediated
relaxations involving Src kinase, PI3-kinase, and MAPKs
Besides the calcium-calmodulin complex, the redox-sensitive
Src/PI3-kinase/Akt and MAPKs pathways have also been shown
to activate eNOS in endothelial cells in response to both
physiological activators such as shear stress and estrogens, and
natural products such as grape-derived polyphenols and tea
catechins [18,20-23]. Since the EPA-induced activation of eNOS
is a calcium-independent event [12], experiments were performed
to determine the role of redox-sensitive Src/PI3-kinase/Akt and
MAPKs pathways in the NO-mediated relaxations to EPA:DHA
6:1. For this purpose, all subsequent experiments were performed
in the presence of indomethacin and TRAM34 plus apamin to
rule out the formation of vasoactive prostanoids and EDH-
mediated responses, respectively. Relaxations to EPA:DHA 6:1
were significantly reduced by the antioxidant N-acetylcysteine, the
membrane permeant mimetic of SOD and the membrane
permeant catalase (MnTMPyP and PEG-catalase, respectively)
and native SOD and catalase (Figures 2 A and B). In addition,
they were also reduced by PP2 (a Src kinase inhibitor),
wortmannin (a PI3-kinase inhibitor), SB203580 (a p38 MAPK
inhibitor), SP600125 (a JNK inhibitor), PD98059 (a MEK
inhibitor, Figures 2C and D). In contrast to EPA:DHA 6:1,
relaxations to bradykinin were not affected by either PD98059,
SP600125, MnTMPyP, PP2 or wortmannin (data not shown) [24-
26]. Thus, these findings indicate that the EPA:DHA 6:1-induced
NO-mediated relaxation is critically dependent on a redox-
Table 1. Characteristics of the different omega-3 fatty acid products.
Fatty acids Purity (in %) Ratio EPA:DHA Content of Omega-3 EPA-DHA as EE Sum Omega-3 as EE (mg/g)
EPA (mg/g) DHA (mg/g)
EPA:DHA 93.4 1:1 476 386 934
EPA:DHA 91.3 6:1 694 121 913
EPA:DHA 46.0 6:1 352 65 460
EPA 99.5 991 995
DHA 98.6 945 986
Fatty acids contents are given in mg/g expressed as ethyl ester (EE).
doi:10.1371/journal.pone.0105102.t001
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sensitive event involving Src kinase/PI3-kinase and MAPKs
pathways.
EPA:DHA 6:1 induces the redox-sensitive Src/PI3-kinase/
Akt- and MAPKs-dependent phosphorylation of eNOS at
Ser 1177
To obtain further evidence that EPA:DHA 6:1 activates Src,
Akt, MAPKs and eNOS, endothelial cells were cultured from
coronary arteries and the phosphorylation level of these proteins at
activator sites (Ser17 for p-Src, Ser473 for p-Akt, Thr183/Tyr185
for p-JNK, Thr180/Tyr182 for p-p38 MAPK, Thr202/Tyr204
for p-ERK, and Ser1177 for p-eNOS) was examined by Western
blot analysis. EPA:DHA 6:1 at 0.4% v/v caused a time-dependent
phosphorylation of Src, Akt and eNOS with significantly increased
levels observed within 5 min and, thereafter, these signals
remained elevated at least up to 2 h (Figure 3A). In addition,
EPA:DHA 6:1 increased to a greater extent the phosphorylation of
Src, Akt and eNOS than EPA:DHA 1:1 (Figure 3B). EPA:DHA
6:1 (0.4% v/v) also significantly increased the phosphorylation
level of p38 MAPK, JNK and ERK (Figure 4B). The possibility
that the redox-sensitive event triggers the Src/PI3-kinase/Akt and
MAPKs pathways leading to eNOS phosphorylation was exam-
ined. The EPA:DHA 6:1-induced phosphorylation of Src, Akt and
eNOS was markedly reduced by MnTMPyP and PEG-catalase
and not significantly affected by native SOD and catalase
(Figure 4A). The EPA:DHA 6:1-induced phosphorylation of
JNK, p38 MAPK and ERK was also markedly reduced by
MnTMPyP whereas SOD, catalase had only minor effects
Figure 1. Omega-3 fatty acids cause endothelium-dependent relaxations, which are dependent on the EPA:DHA ratio and the EPA
plus DHA content. (A, B, C) Coronary artery rings with endothelium were contracted with U46619 before the addition of increasing concentrations
of an omega-3 fatty acid product. (D) Rings were incubated with either L-NA (NO synthase inhibitor), TRAM34 plus apamin (inhibitors of endothelium-
dependent hyperpolarization) or the three inhibitors together for 30 min before the contraction to U46619 and the subsequent relaxation to
EPA:DHA 6:1. All experiments were performed in the presence of indomethacin (10 mM) to prevent the formation of vasoactive prostanoids. Results
are expressed as means6 SEM of 5 different experiments. *P,0.05 versus (A, B) EPA:DHA 6:1 with endothelium, (C) EPA:DHA 6:1 (694:121 mg/g) with
endothelium, and (D) control.
doi:10.1371/journal.pone.0105102.g001
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(Figure 4B). PEG-catalase did not significantly affect the phos-
phorylation of JNK and p38 MAPK but reduced that of ERK
(Figure 4B). Thus, these findings suggest that intracellular ROS, in
particular superoxide anions, are upstream activators of the Src/
PI3-kinase/Akt and MAPKs pathways leading to eNOS activation
in response to EPA:DHA 6:1.
EPA:DHA 6:1 induces a pro-oxidant response in coronary
artery endothelial cells
Experiments were performed to determine whether EPA:DHA
6:1 stimulates the endothelial formation of ROS in coronary artery
sections using the redox-sensitive fluorescent probe dihydroethi-
dium (DHE). EPA:DHA 6:1 markedly increased the fluorescence
signal in the endothelium whereas the signal in the smooth muscle
was minimally affected (Figure 5A). The stimulatory effect of
EPA:DHA 6:1 was markedly reduced by MnTMPyP and PEG-
SOD, and, to a lesser extent, by PEG-catalase, and not affected by
SOD and catalase (Figure 5A). In addition, EPA:DHA 6:1
significantly increased the formation of superoxide anions in
cultured endothelial cells as assessed using ESR and the cell
permeable spin probe CMH, and this effect was inhibited by SOD
and PEG-SOD (Figure 5B). Moreover, EPA:DHA 6:1 significant-
ly increased the formation of hydrogen peroxide in cultured
endothelial cells as assessed using the Amplex Red based assay,
and this effect was inhibited by PEG-catalase but not by catalase
(Figure 5C). Altogether, these findings indicate that EPA:DHA 6:1
induces a pro-oxidant response in endothelial cells involving both
superoxide anions and hydrogen peroxide.
Figure 2. The EPA:DHA 6:1-induced endothelium-dependent NO-mediated relaxation involves a redox-sensitive event. Coronary
artery rings with endothelium were incubated either with (A) an antioxidant (N-acetylcysteine), an extracellular scavenger of superoxide anions (SOD),
a membrane permeant mimetic of superoxide dismutase (MnTMPyP), (B) extracellular and membrane permeant analogue of catalase (catalase and
PEG-catalase, respectively), (C) an inhibitor of either Src kinase (PP2) or PI3-kinase (wortmannin), (D) an inhibitor of either p38 MAPK (SB203580), MEK
(PD98059) or JNK (SP600125) for 30 min before the addition of U46619 and the subsequent relaxation to EPA:DHA 6:1. All experiments were
performed in the presence of indomethacin (10 mM) and TRAM34 plus apamin (both at 100 nM) to rule out the formation of vasoactive prostanoids
and endothelium-dependent hyperpolarization-mediated responses, respectively. Results are presented as means 6 SEM of 5 different experiments.
*P,0.05 versus control.
doi:10.1371/journal.pone.0105102.g002
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Discussion
The major findings of the present study indicate that the ability
of omega-3 fatty acid products to cause endothelium-dependent
relaxations involving predominantly NO and also, to some extent
endothelium-dependent hyperpolarization in coronary arteries,
depends on the formulation and the content of EPA and DHA,
and that the EPA:DHA 6:1 is a superior formulation than
EPA:DHA 1:1. They further indicate that the stimulatory effect of
EPA:DHA 6:1 leading to eNOS activation involves the Src/PI3-
kinase/Akt and MAPKs pathways with the subsequent phosphor-
ylation of eNOS at the activator site Ser1177. Moreover, a redox-
sensitive intracellular event involving superoxide anions and
hydrogen peroxide has been identified as an early event triggering
the activation of the Src/PI3-kinase/Akt and MAPKs pathways in
endothelial cells. Thus, endothelial cells appear to act as special
sensors of omega-3 fatty acids in the arterial wall to increase in a
sustained manner the eNOS-derived formation of NO, and,
hence, vascular protection.
The evaluation of the ability of different omega-3 fatty acid
products to relax porcine coronary arteries has indicated that
EPA, DHA and formulations with different ratios of EPA:DHA
induced pronounced relaxations in intact arterial preparations
whereas they had little effects in rings without endothelium.
Moreover, although EPA and DHA alone evoked similar
concentration-relaxation curves up to 0.2% (v/v), their combina-
tion in the formulation EPA:DHA 6:1 and 9:1 demonstrated
superiority to the formulation EPA:DHA 3:1, 1:1, 1:3, 1:6 and 1:9.
The mechanism accounting for such a synergistic effect remains
unclear. Potential explanations could be that the integration of
omega-3 fatty acids into membrane lipids and/or that the stability
Figure 3. EPA:DHA 6:1 induces the phosphorylation of Src, Akt and eNOS in porcine coronary artery endothelial cells in a time- and
EPA:DHA ratio-dependent manner. (A) Cultured endothelial cells were exposed to EPA:DHA 6:1 (0.4% v/v) for the indicated times at 37uC. (B)
Cultured endothelial cells were exposed to products with either an EPA:DHA ratio of 6:1 or 1:1 at the concentration of 0.4% (v/v) for 30 min at 37uC.
Representative immunoblots of p-Src, p-Akt and p-eNOS proteins as assessed by Western blot analysis (top), and corresponding cumulative data
(bottom). Results are shown as means 6 SEM of 3 different experiments. *P,0.05 versus control, #P,0.05 versus EPA:DHA 6:1 treatment.
doi:10.1371/journal.pone.0105102.g003
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of the omega-3 fatty acids are dependent on an optimal EPA:DHA
ratio. Indeed, EPA but not DHA has also been shown to cause
cerebral microvascular vasodilatation involving arachidonic acid
metabolites [15], whereas DHA but not EPA supplementation
improved forearm microvascular reactivity in overweight hyper-
lipidemic men [16]. The characterization of the omega-3 fatty
acid-induced endothelium-dependent relaxation has indicated a
predominant role of NO, and also, to some extent, endothelium-
dependent hyperpolarization whereas vasoactive prostanoids are
not involved. Previous studies have also shown an increased
endothelium-dependent relaxation or vasodilatation in response to
the acute addition of EPA [12], and the chronic administration of
EPA (3.5 g daily) and DHA (1.5 g daily) in pigs [7,27], and an
increased vasodilatation to EPA (1.8 g daily) in humans [28].
Although omega-3 fatty acids are potent inducers of the
endothelial formation of NO, the underlying mechanism remains
poorly characterized. Activation of eNOS can be triggered by
elevations in intracellular calcium by calcium elevating agonists
such as bradykinin and thrombin, subsequently to the binding of
the calcium-calmodulin complex to eNOS and the dissociation of
the enzyme from its inhibitor caveolin [29]. Although EPA
induced elevations in intracellular calcium in endothelial cells,
these responses were very small and did not contribute to eNOS
activation [12]. EPA and DHA have also been shown to alter
caveolae microenvironment not only by modifying membrane
lipid composition but also by changing distribution of major
structural proteins, which may eventually lead to eNOS activation
[30,31]. The present findings provide evidence for an additional
mechanism of eNOS activation by omega-3 fatty acids via the
Src/PI3-kinase/Akt and MAPKs pathways leading to the phos-
phorylation of eNOS at the activator site Ser1177. Indeed,
inhibitors of either Src kinase, PI3-kinase, JNK, p38 MAPK or
MEK reduced NO-mediated relaxations to EPA:DHA 6:1, and
EPA:DHA 6:1 increased the phosphorylation level of activator
sites of Src, Akt, JNK, p38 MAPK, ERK and eNOS in endothelial
cells. Of interest, the Src/PI3-kinase/Akt pathway has also been
shown to mediate the stimulatory effect of other natural products
containing high levels of polyphenols such as grape-derived
products and tea catechins on eNOS [17,18,22,23]. Similarly to
polyphenols [17,18,22,23], the intracellular formation of ROS, in
particular superoxide anions and hydrogen peroxide, mediates the
stimulatory effect on the Src/PI3-kinase/Akt and MAPKs
Figure 4. The EPA:DHA 6:1-induced phosphorylation of Src, Akt, eNOS, JNK, p38 MAPK and ERK is a redox-sensitive event
involving predominantly superoxide anions in endothelial cells. Endothelial cells were incubated either with solvent, MnTMPyP (100 mM),
SOD (500 U/ml), catalase (500 U/ml) or PEG-catalase (500 U/ml) for 30 min before the addition of EPA:DHA 6:1 (0.4% v/v) for 30 min. Representative
immunoblots for detection of (A) p-Src, p-Akt and p-eNOS and (B) p-JNK, p-p38 MAPK and p-ERK (top), and corresponding cumulative data (bottom).
Results are shown as means 6 SEM of 3-4 different experiments except for p-ERK (n = 2). *P,0.05 versus control, #P,0.05 versus EPA:DHA 6:1
treatment.
doi:10.1371/journal.pone.0105102.g004
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pathways leading to eNOS activation in response to EPA:DHA
6:1. Indeed, inhibitors of intracellular oxidative stress and in
particular the membrane permeant mimetic of SOD, MnTMPyP,
markedly reduced the relaxation and the phosphorylation of Src,
Akt, JNK, p38 MAPK, ERK and eNOS in response to EPA:DHA
6:1. Moreover, the redox-sensitive probe dihydroethidium pro-
vided direct evidence that EPA:DHA 6:1 induced the formation of
ROS in the native endothelium whereas the signal in the smooth
muscle was minimally affected. Furthermore, EPA:DHA 6:1-
induced the generation of superoxide anions and hydrogen
peroxide in cultured endothelial cells as assessed using the ESR
technique with the cell permeable spin probe CMH and the
Amplex Red assay, respectively. Native SOD and catalase did not
affect the EPA:DHA 6:1-induced phosphorylation of target
proteins and the increased DHE fluorescence signal in the native
endothelium of coronary artery sections. However, both com-
pounds reduced NO-mediated relaxations, such a difference is
most likely due to different experimental conditions and in
particular to the high partial oxygen pressure in the vascular
reactivity studies (aerated with 95% O2) compared to that in
experiments using cultured endothelial cells (aerated with 18-20%
O2) and coronary artery sections (ambient air, 21% O2). Besides
endothelial cells, the induction of oxidative stress in response to
omega-3 fatty acids has also been observed in several types of
cancer cells including MCF-7 [32], and vascular smooth muscle
cells to induce apoptosis [33]. The oxidative stress-induced
apoptosis has been suggested to involve lipid peroxidation [32],
and a calcium-regulated event [33].
In conclusion, the ability of omega-3 fatty acids to stimulate the
endothelial formation of NO is dependent on the ratio and
amount of the EPA:DHA formulation, and it involves an original
pathway triggered by the intracellular oxidative stress leading to
the activation of the Src/PI3-kinase/Akt and MAPKs pathways to
increase ultimately eNOS activity.
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